Ethanolamine kinase
Ethanolamine kinase (EK) is an enzyme that catalyzes the phosphorylation of ethanolamine, a primary amine and a primary alcohol. This reaction is the first step in the CDP-ethanolamine pathway, which is the primary method for the synthesis of phosphatidylethanolamine in mammalian cells.
Function[edit]
Ethanolamine kinase catalyzes the ATP-dependent phosphorylation of ethanolamine, producing phosphoethanolamine and ADP. This is the first step in the CDP-ethanolamine pathway, which ultimately leads to the production of phosphatidylethanolamine. Phosphatidylethanolamine is a major component of the inner leaflet of the lipid bilayer in mammalian cells and is involved in many cellular processes, including protein folding and membrane fusion.
Structure[edit]
The structure of ethanolamine kinase is not fully understood. However, it is known to be a monomer and is believed to have a two-domain structure. The larger domain is thought to bind ATP and ethanolamine, while the smaller domain is believed to be involved in the transfer of the phosphate group.
Clinical significance[edit]
Alterations in the activity of ethanolamine kinase have been implicated in several diseases. For example, increased activity of this enzyme has been observed in cancer cells, suggesting that it may play a role in tumor growth and progression. Additionally, mutations in the gene encoding ethanolamine kinase have been associated with neurological disorders.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian